The role of hyaluronan synthesis and degradation in the critical respiratory illness COVID-19
- PMID: 35442830
- PMCID: PMC9126216
- DOI: 10.1152/ajpcell.00071.2022
The role of hyaluronan synthesis and degradation in the critical respiratory illness COVID-19
Abstract
Hyaluronan (HA) is a polysaccharide found in all tissues as an integral component of the extracellular matrix (ECM) that plays a central regulatory role in inflammation. In fact, HA matrices are increasingly considered as a barometer of inflammation. A number of proteins specifically recognize the HA structure and these interactions modify cell behavior and control the stability of the ECM. Moreover, inflamed airways are remarkably rich with HA and are associated with various inflammatory diseases including cystic fibrosis, influenza, sepsis, and more recently coronavirus disease 2019 (COVID-19). COVID-19 is a worldwide pandemic caused by a novel coronavirus called SARS-CoV-2, and infected individuals have a wide range of disease manifestations ranging from asymptomatic to severe illness. Critically ill COVID-19 patient cases are frequently complicated by development of acute respiratory distress syndrome (ARDS), which typically leads to poor outcomes with high mortality rate. In general, ARDS is characterized by poor oxygenation accompanied with severe lung inflammation, damage, and vascular leakage and has been suggested to be linked to an accumulation of HA within the airways. Here, we provide a succinct overview of known inflammatory mechanisms regulated by HA in general, and those both observed and postulated in critically ill patients with COVID-19.
Keywords: ARDS; COVID-19; coronavirus; hyaluronan; inflammation.
Conflict of interest statement
No conflicts of interest, financial or otherwise, are declared by the authors.
This article is part of the special collection "Deciphering the Role of Proteoglycans and Glycosaminoglycans in Health and Disease." Liliana Schaefer, MD, served as Guest Editor of this collection.
Figures


Similar articles
-
Hyaluronan in the pathogenesis of acute and post-acute COVID-19 infection.Matrix Biol. 2023 Feb;116:49-66. doi: 10.1016/j.matbio.2023.02.001. Epub 2023 Feb 5. Matrix Biol. 2023. PMID: 36750167 Free PMC article. Review.
-
Unraveled roles of hyaluronan in severe COVID-19.EXCLI J. 2021 Jan 15;20:117-125. doi: 10.17179/excli2020-3215. eCollection 2021. EXCLI J. 2021. PMID: 33564281 Free PMC article. Review.
-
SARS-CoV-2 infection induces hyaluronan production in vitro and hyaluronan levels in COVID-19 patients relate to morbidity and long-term lung impairment: a prospective cohort study.mBio. 2024 Oct 16;15(10):e0130324. doi: 10.1128/mbio.01303-24. Epub 2024 Sep 20. mBio. 2024. PMID: 39302125 Free PMC article.
-
Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series.Stem Cell Res Ther. 2021 Jan 29;12(1):91. doi: 10.1186/s13287-021-02165-4. Stem Cell Res Ther. 2021. PMID: 33514427 Free PMC article. Clinical Trial.
-
Extracorporeal Membrane Oxygenation (ECMO) in Critically Ill Patients with Coronavirus Disease 2019 (COVID-19) Pneumonia and Acute Respiratory Distress Syndrome (ARDS).Med Sci Monit. 2020 Aug 6;26:e925364. doi: 10.12659/MSM.925364. Med Sci Monit. 2020. PMID: 32759887 Free PMC article. Review.
Cited by
-
Simple virus-free mouse models of COVID-19 pathologies and oral therapeutic intervention.iScience. 2024 Feb 13;27(3):109191. doi: 10.1016/j.isci.2024.109191. eCollection 2024 Mar 15. iScience. 2024. PMID: 38433928 Free PMC article.
-
Elevated hyaluronic acid levels in severe SARS-CoV-2 infection in the post-COVID-19 era.Front Cell Infect Microbiol. 2024 Feb 8;14:1338508. doi: 10.3389/fcimb.2024.1338508. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38390620 Free PMC article.
-
Pulmonary Function and Survival 1 Year After Dupilumab Treatment of Acute Moderate to Severe Coronavirus Disease 2019: A Follow-up Study From a Phase 2a Trial.Open Forum Infect Dis. 2024 Jan 3;11(2):ofad630. doi: 10.1093/ofid/ofad630. eCollection 2024 Feb. Open Forum Infect Dis. 2024. PMID: 38312212 Free PMC article. Clinical Trial.
-
Hyaluronan in the pathogenesis of acute and post-acute COVID-19 infection.Matrix Biol. 2023 Feb;116:49-66. doi: 10.1016/j.matbio.2023.02.001. Epub 2023 Feb 5. Matrix Biol. 2023. PMID: 36750167 Free PMC article. Review.
References
-
- WHO. COVID-19 situation reports. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situatio... [Accessed: 2/1/2022].
-
- Center for Systems Science and Engineering at Johns Hopkins University. COVID-19 dashboard. https://coronavirus.jhu.edu/map.html. opens in new tab [Accessed: 2/1/2022].
-
- Noorimotlagh Z, Karami C, Mirzaee SA, Kaffashian M, Mami S, Azizi M. Immune and bioinformatics identification of T cell and B cell epitopes in the protein structure of SARS-CoV-2: a systematic review. Int Immunopharmacol 86: 106738–106738, 2020. doi:10.1016/j.intimp.2020.106738. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous